ACADIA Pharmaceuticals Inc. (LON:0A4W)
London
· Delayed Price · Currency is GBP · Price in USD 18.62
-0.02 (-0.11%)
At close: Jan 31, 2025
ACADIA Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 319.59 | 188.66 | 114.85 | 147.44 | 326.03 | Upgrade
|
| Short-Term Investments | 436.4 | 250.21 | 301.98 | 373.27 | 305.93 | Upgrade
|
| Cash & Short-Term Investments | 755.99 | 438.87 | 416.82 | 520.71 | 631.96 | Upgrade
|
| Cash Growth | 72.26% | 5.29% | -19.95% | -17.60% | -9.39% | Upgrade
|
| Accounts Receivable | 98.74 | 98.27 | 62.2 | 64.37 | 48.25 | Upgrade
|
| Other Receivables | 5.96 | 4.08 | 0.89 | 0.98 | 2.04 | Upgrade
|
| Receivables | 104.7 | 102.35 | 63.08 | 65.34 | 50.28 | Upgrade
|
| Inventory | 21.95 | 35.82 | 6.64 | 7.88 | 9.68 | Upgrade
|
| Prepaid Expenses | 55.68 | 39.09 | 21.4 | 23.89 | 25.69 | Upgrade
|
| Total Current Assets | 938.32 | 616.13 | 507.94 | 617.82 | 717.62 | Upgrade
|
| Property, Plant & Equipment | 50.79 | 56.47 | 61.59 | 66.32 | 56.44 | Upgrade
|
| Long-Term Investments | - | - | - | 3.6 | 1.3 | Upgrade
|
| Other Intangible Assets | 119.78 | 65.49 | - | - | 1.11 | Upgrade
|
| Other Long-Term Assets | 78.87 | 10.87 | 18.28 | 12.38 | 6.15 | Upgrade
|
| Total Assets | 1,188 | 748.96 | 587.81 | 700.12 | 782.62 | Upgrade
|
| Accounts Payable | 16.19 | 17.54 | 12.75 | 6.88 | 8.49 | Upgrade
|
| Accrued Expenses | 266.46 | 197.72 | 103.58 | 80.89 | 92.39 | Upgrade
|
| Current Portion of Leases | 9.96 | 9.41 | 9.31 | 8.3 | 5.09 | Upgrade
|
| Other Current Liabilities | 102.26 | 29.58 | - | - | - | Upgrade
|
| Total Current Liabilities | 394.87 | 254.25 | 125.63 | 96.07 | 105.97 | Upgrade
|
| Long-Term Leases | 42.04 | 47.8 | 52.7 | 56.13 | 44.46 | Upgrade
|
| Other Long-Term Liabilities | 18.06 | 15.15 | 9.07 | 7.03 | 5.18 | Upgrade
|
| Total Liabilities | 454.96 | 317.2 | 187.4 | 159.23 | 155.61 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 2,937 | 2,863 | 2,771 | 2,695 | 2,613 | Upgrade
|
| Retained Earnings | -2,204 | -2,431 | -2,370 | -2,154 | -1,986 | Upgrade
|
| Comprehensive Income & Other | 0.29 | 0.02 | -0.98 | -0.19 | 0.04 | Upgrade
|
| Shareholders' Equity | 732.79 | 431.76 | 400.41 | 540.89 | 627.01 | Upgrade
|
| Total Liabilities & Equity | 1,188 | 748.96 | 587.81 | 700.12 | 782.62 | Upgrade
|
| Total Debt | 52 | 57.21 | 62 | 64.43 | 49.55 | Upgrade
|
| Net Cash (Debt) | 704 | 381.66 | 354.82 | 456.28 | 582.41 | Upgrade
|
| Net Cash Growth | 84.46% | 7.56% | -22.24% | -21.66% | -15.30% | Upgrade
|
| Net Cash Per Share | 4.23 | 2.33 | 2.19 | 2.84 | 3.70 | Upgrade
|
| Filing Date Shares Outstanding | 166.79 | 164.77 | 162.23 | 161.2 | 160.05 | Upgrade
|
| Total Common Shares Outstanding | 166.71 | 164.65 | 162.06 | 161.01 | 159.64 | Upgrade
|
| Working Capital | 543.45 | 361.87 | 382.31 | 521.76 | 611.65 | Upgrade
|
| Book Value Per Share | 4.40 | 2.62 | 2.47 | 3.36 | 3.93 | Upgrade
|
| Tangible Book Value | 613.01 | 366.27 | 400.41 | 540.89 | 625.9 | Upgrade
|
| Tangible Book Value Per Share | 3.68 | 2.22 | 2.47 | 3.36 | 3.92 | Upgrade
|
| Machinery | 10.16 | 10.42 | 10.42 | 10.54 | 9.08 | Upgrade
|
| Construction In Progress | 0.52 | - | - | - | - | Upgrade
|
| Leasehold Improvements | 3.75 | 3.75 | 3.7 | 3.7 | 4.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.